Impact of Mutational Status on Intracellular Effects of Cell-Permeable CaaX Peptides in Pancreatic Cancer Cells

  • 0Department of Chemistry and Biochemistry, Institute of Biochemistry, University of Cologne, Zuelpicher Str. 47a, 50674, Cologne, Germany.

Summary

This summary is machine-generated.

Cell-permeable CaaX-peptides interfere with protein prenylation, impacting KRas signaling differently in pancreatic cancer cells with wildtype versus mutated KRas. These peptides show promise for studying prenylated proteins.

Area Of Science

  • Biochemistry
  • Cell Biology
  • Cancer Research

Background

  • Prenyltransferases attach lipid groups to proteins via CaaX motifs, enabling membrane association crucial for signaling and trafficking.
  • Posttranslational modification by prenylation is vital for protein function in cellular processes like signaling and apoptosis.
  • Cell-permeable CaaX-peptides are emerging tools to modulate protein prenylation.

Purpose Of The Study

  • To investigate the relevance of KRas mutational status in pancreatic cancer cells treated with CaaX-peptides.
  • To compare the effects of CaaX-peptides on KRas wildtype (BxPC-3) and KRas mutated (PANC-1) pancreatic cancer cells.
  • To elucidate the impact of CaaX-peptides on KRas localization and downstream signaling pathways.

Main Methods

  • Comparative analysis of CaaX-peptide activity in KRas wildtype and mutated pancreatic cancer cell lines.
  • Assessment of CaaX-peptide internalization in different cell lines.
  • Evaluation of KRas plasma membrane localization and downstream signaling alterations.

Main Results

  • CaaX-peptides differentially affect KRas wildtype and mutated pancreatic cancer cells despite similar internalization rates.
  • Altered KRas plasma membrane localization was observed in PANC-1 cells, suggesting disturbed prenylation.
  • CaaX-peptides influenced KRas signaling and KRas-dependent regulators like NF1 and SOS1, with effects dependent on KRas mutation status.

Conclusions

  • CaaX-peptides exhibit differential effects on pancreatic cancer cells based on KRas mutational status.
  • CaaX-peptides can disrupt KRas prenylation and alter its plasma membrane localization in KRas-mutated cells.
  • CaaX peptides are valuable tools for studying prenylated proteins and hold therapeutic potential for cancer treatment.